Osteoblasts and osteoclasts: A remarkable cooperation between mesenchymal and hematopoietic cells;Osteoblastes et osteoclastes: Une cooperation exemplaire entre cellules mesenchymateuses et cellules hematopoietiques

Hematologie

Volumn 6, Issue 1, 2000, Pages 6-16

  Boissy, Patrice ^a   Malaval, Luc ^b   Jurdic, Pierre ^a  

^a UNIVERSITÉ DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Bone; Differentiation; Hematopoiesis; Monocytes; OPGL ODF RANKL TRANCE; Osteoblasts; Osteoclasts

Indexed keywords

CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR;

BONE MATRIX; BONE REMODELING; CELL INTERACTION; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; MESENCHYME; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; REVIEW;

EID: 0034020627     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Bianco P, Cossu G Uno, nessuno e centomila searching for the identity of mesodermal progenitors Exp Cell Res 1999 , 251 : 257-63
2. Aubin JE, LIU F The osteoblast lineage In Bilezikian JP, Raisz LG, Rodan GA, eds Principles of bone biology, San Diego Academic Press, 1996 : 51-67.
3. Schmiti JM, Hwang K, Winn SR, Hollinger JO Bone morphogenetic proteins an update on basic biology and clinical relevance J Orthopaed Res 1999 , 17 269-78
4. Grigoriadis A, Wang ZQ, Wagner EF Regulation of bone cell differentiation and bone remodelling by the c-Fos/AP-1 transcription factor. In . Bilezikian JP, Raisz LG, Rodon GA, eds Principles of bone biology San Diego Academic Press, 1996 15-24.
5. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS Developmental expression and activities of specific Fos end Jun proteins are functionally related to osteoblast maturation role of Fra-2 and Jun D during differentiation Endocrinology 1996, 137 4390-408
6. Mo L, Golden S, Maxson R The molecular basis of Boston type craniosynostosis the Pro148: his mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucieotide sequence preferences Hum Mol Genet 1996 , 10 1915-920
7. Dodig M, Tadic T, Kronenberg MS, Dadic S, Liu YH, Maxson R, Rowe DW, Lichter AC Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation Dev Biol 1999 , 209 298-307.
8. Liu YH, Tnag Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE Jr. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing skull a posible mechanism for MSX2-medialed craniosynostosis in humans Dev Biol 1999, 205 260-74
9. Newberry EP, Boudreaux JM, Towler DA. Stimulus-selective inhibition of rat osteocalcin promoter induction and protein-DNA interactions by the homeodomain represser Msx2 J Biol Chem 1997 , 272 . 29607-13
10. Chen X, Li X, Wang W, Lufkin T Dlx5 and Dlx6 an evolutionary conserved pair of murine homeobox genes expressed in the embryonic skeleton Ann N Y Acad Sci 1996 , 785 38-47
11. Ryoo HM, Hoffmann HM, Beumer T, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijnen AJ, Lian JB Stage-specific expression of Dlx-5 during osteoblast differentiation involvement in regulation of osteocalcin gene expression Mol Endocrinol 1997 ; 11 1681-94
12. Miyama K, Yamada G, Yamamoto TS, Takagi C, Miyodo K, Sakai M, Ueno N, Shibuya H A BMP-inducible gene, Dlx5, regulates osteoblast differentiation and mescderm induction. Dev Biol 1999 , 208 . 123-33
13. Newberry EP, Latifi T, Towler DA Reciprocal regulation of osteocalcin transcription by the homeodomain proteins msx2 and dlx5 Biochemistry 1998 , 37 16360-8.
14. Newberry EP, Latifi T, Towler DA The RRM domain of MINT, a novel Msx2 binding protein, recognizes and regulates the rat osteocolcin promoter Biochemistry 1999, 38 10678-90
15. Komori T, Yagi H, Nomura S, Yamagushi A, Sasaki K, Degushi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 1997 ; 89 : 755-64
16. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ Cbfal, a candidate gene for cleidocraniol dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997 , 89 765-71
17. Mundlos S Cleidocranial dysplasia : clinical and molecular genetics J Med Genet 1999 , 36 177-82.
18. Ducy P, Zhang R, Geofroy V, Ridall AL, Karsenty G. Osf2/Cbfa1 a transcriptional activator of osteoblast differentiation Cell 1997 , 89 747-54.
19. Komori T Cbfa I, a transcription factor for osteoblast differentiation J Bone Miner Metab 1998 ; 16. 14
20. Roméo PH. Caracténsation et fonction des protéines de fusion exprimées dans les leucé mies. Médecine Thérapeutique 1998 , 4 291-8
21. Xiao ZS, Hinson TK, Quarles LD Cbfa 1 isoform overexpression upregulaies osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J Cell Biochem 1999 , 74 596-605
22. Harada H, Tagashira S, Fujiwara M, Ogawa S, Kaisumata T, Yamaguchi A, Komori T, Nakatsuka M Cbfa 1 isoforms exeri functional differences m osteoblast differentiation. J Biol Chem 1999, 274 : 6972-8
23. Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control espression of a mouse osteocalcin gene. Mol Cell Biol 1995 , 15 1858-69.
24. Xiao ZS, Thomas R, Hinson TK, Quarles LD. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor Gene 1998 : 214 : 187-97.
25. Geoffroy V, Corial DA, Zhou L, Lee B, Karsenty G Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function Mammalian Genome 1998 , 9 54-7
26. Ducy P, Starbuck M, Piiemel M, Shen JH, Pinero G. Geoffroy V, Amling M, Karsenty G A Cbfa 1-dependent genetic pathway controls bone formation beyond embryonic development Gene Develop 1999 13 1025-36
27. Schinke T, Karsenty G Characterization of Osf 1, an osteoblast-specifjc transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters J Biol Chem 1999,274 30182-9
28. Horton MA, Taylor ML, Arnett TR, Helfrich MH. Arg-Gly-Asp [RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 1991 , 195 368-75
29. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Setile SL, Ruminski PG, Teitelbaum SL A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo [see comments] J Clin Invest 1997 ; 99 : 2284-92
30. Lakkakorpi PT, Helfrich MH, Horton MA, Vaananen HK Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts A study using confocal laser scanning microscopy J Cell Sci 1993 , 104 . 663-70
31. Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA, Duong LT Role of avb3 integrin in osteoclast migration and formation of the sealing zone [in process citation]. J Cell Sci 1999 , 112 : 3985-93
32. Boissy P, Machuca I, Pfaff M, Ficheux D, Jurdic P Aggregation of mononucleated precursors triggers cell surface expression of alpha vbeta3 integrin, essential to formation of osteoclast-like multinucleated cells J Cell Sci 1998 , 111 2563-74.
33. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ Abundant calcitonin receptors in isolated rat osteoclasts Biochemical and autoradiographic characterization J Clin Invest 1986, 78 355-60
34. Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beerisen W Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 1992 ; 150 . 221-31
35. Jotereau FV, Le Douarin NM The development relationship between osteocytes and osteoclasts : a study using the quail-chick nuclear marker in endochondral ossification Dev Biol 1978 ; 63 253-65
36. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures Endocrinology 1988 , 122 : 1373-82
37. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T. Osteoblastic cells are involved in osteoclast formation Endocrinology 1988 , 123 2600-2
38. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanosou NA Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells Calcif Tissue Int 1998 , 62 527-31
39. Solari F, Flamant F, Cherel Y, Wyers M, Jurdic P The osteoclast generation : an in vitro and in vivo study with a genetically labelled avion monocylic cell line J Cell Sci 1996 , 109 1203-13.
40. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells Endocrinology 1989 , 125 1805-13
41. Alvarez JI, Ross FP, Athanasou NA, Blair HC, Greenfield EM, Teitelbaum SL Osteoclast precursors circulate in avian blood Calcif Tissue Int 1992 ; 51 48-53
42. Mbalaviele G, Orcel P, Morieux C, Nijweide PJ, de Vernejoul MC Osteoclast formation from human cord blood mononuclear cells co-cultured with mice embryonic metatarsals in the presence of M-CSF Bone 1995 , 16 171-7
43. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, et al Osteoprotegerin a novel secreted protein involved in the regulation of bone density. Cell 1997 , 89 309-19
44. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG) : a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 1998 , 139 1329-37
45. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis Biochem Biophys Res Commun 1997 , 234 137-42
46. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin Biochem Biophys Res Commun 1998 , 247 610-5
47. Yosuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 1998 , 95 3597-602
48. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T. Higashio K A novel molecular mechanism modulating osteoclast differentiation and function. Bone 1999 , 25 109-13
49. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 1998 , 93 165-76
50. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 1997 ; 390 : 175-9
51. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartleft FS 3rd, Frankel WN, Lee SY, Choi Y TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells J Biol Chem 1997 , 272 : 251904.
52. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Marony S, Oliveirados-Santos AJ, Van GJ. Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 1999 ; 397 315-23
53. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures Biochem Biophys Res Commun 1998 , 246 199-204
54. Nakagawa N, Kinosoki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclasiogenesis Biochem Biophys Res Commun 1998 , 253 395-400.
55. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedi T, Daro E, Smith J, Tometsko ME, Maliszewski CR RANK is essential for osteoclast and lymph node development Genes Dev 1999 , 13 : 2412-24
56. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U Requirement for NF-kappaB in osteoclast and B-cell development Genes Dev 1997 , 11 : 3482-96.
57. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligond Proc Natl Acod Sci USA 1999 ; 96 : 3540-5.
58. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T Severe osteopetrosis, defective interleukm-1 signalling and lymph node organogenesis in TRAF6-deficient mice Genes Cells 1999 , 4 353-62.
59. Quinn JM, Elliott J, Gillespie MT, Moitin TJ A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998 , 139 4424-7
60. Rubin J, Fan X, Thornton D, Bryani R, Biskobing D Regulation of murine osteoblast macrophage colony-stimulating factor production by 1,25(OH)2D3. Calcif Tissue Int 1996, 59 291-6.
61. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokowa T, Suda T. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors J Clin Invest 1993; 91 257-63
62. Jimi E, Nakamura I, Duong LT, lkebe T, Takahashi N, Radon GA, Suda T Interleukin I induces multinucleation and bone-resorbing activity of osleoclasis in the absence of osteoblasts/stromal cells Exp Cell Res 1999 , 247 : 84-93.
63. Lagasse E, Weissman IL Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997 ; 89 1021-31.
64. Wani MR, Fuller K, Kim NS, Choi Y, Chambers T Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors . synergistic activation of differentiation, cell spreading, and fusion Endocrinology 1999 , 140 1927-35
65. Okazaki R, Toriumi M, Fukumoto S, Miyamoto M, Fujita T, Tanaka K, Takeuchi Y Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro Endocrinology 1999, 140 5060-5
66. Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, Baron R, Karsenty G Dissociation between bone resorption and bone formation in osteopenic transgenic mice Proc Natl Acad Sci USA 1998 ; 95 13835-40
67. Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A Potential role of Cbfa I, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis regulation of mRNA expression of osteoclast differentiation factor (ODF) Biochem Biophys Res Commun 1998 , 252 : 697-702
68. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mc-Cabe S Activated T cells regulate bone loss and Joint destruction in adjuvant arthritis through osteoprotegerni ligand Nature 1999 , 402 304-9
69. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT Activated T lymphocytes support osleoclast formation in vitro Biochem Biophys Res Commun 1999 , 265 144-50